NF-κB is also activated in PMBL [2, 8, 52], but FOXP1, which we identified as the target of miR-92a, is down-regulated in PMBL, and cannot be involved in the same way as in DLBCL. The gene discussed is FOXP1; the disease is diffuse large B-cell lymphoma.